CV Sciences Archives

StaffMarch 12, 2019

It’s time for your Daily Hit of cannabis financial news for March 12, 2019. On The Site Corbus Pharmaceuticals Synthetic cannabis pharmaceutical company Corbus Pharmaceuticals Holdings Inc.(CRBP) reported earnings for the fourth quarter and the full year ending in December. For the quarter, Corbus delivered a net loss of approximately $17,306,000 or a net loss per diluted share […]

Debra BorchardtAugust 28, 2018

CV Sciences, Inc. (CVSI) issued a statement denying that it had violated securities laws. The statement stemmed from a claim by Citron Research that CV Sciences had a patent application rejected by the United States Patent and Trademark Office (USPTO). Initially, CV Sciences stock popped 25% in one day prompting Citron to release the negative […]

William SumnerAugust 1, 2018

CV Sciences (CVSI), a company dedicated to developing CBD oil products and novel therapeutics utilizing synthetic CBD, today announced its financial results for the second quarter, which ended on June 30, 2018. The stock popped almost 5% on the news sending the price to approximately $3.31 for a 52-week high. Most recently the company announced […]

StaffJuly 25, 2018

It’s time for your Daily Hit of cannabis financial news for July 25, 2018. On the Site New Mexico Sales Though marijuana remains illegal in New Mexico for recreational use, the growth seen for medicinal purposes has surged in 2018, surpassing $50 million in sales, due in large part to a huge rise in patient […]

StaffJune 27, 2018

It’s time for your Daily Hit of cannabis financial news for June 27, 2018. On The Site Canopy Growth Corporation Canopy Growth Corporation (CGC) reported that its fourth-quarter revenue rose 55% to C$22.8 million versus last year’s C$14.7 million for the same time period. Still, the company recorded a net loss of C$61.5 million or C$0.31 per basic and diluted […]

Jack SmithMarch 29, 2018

CV Sciences (CVSI) saw a 126% jump in revenue in its just reported fourth-quarter, due in large part to its continued push into the organic cannabis market. The company, which has offices in Las Vegas and San Diego, said fourth-quarter sales came in at $7.24 million, up 126 percent year over year. Gross profit also experienced […]

William SumnerMarch 6, 2018

mCig mCig Inc. (MCIG) announced today that its subsidiary, NYAcres Inc. will conduct a joint venture with FarmOn! Foundation, which was just granted permission to participate in an Industrial Hemp Agricultural Research Pilot program through the New York State Department of Agriculture & Markets. The company expects that first harvests, which will be grown on […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: CV Sciences

The Daily Hit: March 12, 2019

CV Sciences Denies It Violated Securities Laws

Sales Jumped 203% for CV Sciences in the Second Quarter

The Daily Hit: July 25, 2018

The Daily Hit: June 27 2018

CV Sciences Sees 126% Jump In Q4 Revenue, Aided By Organic Expansion

The Daily Hit: Today’s Cannabis Briefs

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox